Page last updated: 2024-11-05

tetraethylammonium and Long QT Syndrome

tetraethylammonium has been researched along with Long QT Syndrome in 2 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jow, F1
Tseng, E1
Maddox, T1
Shen, R1
Kowal, D1
Dunlop, J1
Mekonnen, B1
Wang, K1
Smith, PL1
Baukrowitz, T1
Yellen, G1

Other Studies

2 other studies available for tetraethylammonium and Long QT Syndrome

ArticleYear
Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
    Assay and drug development technologies, 2006, Volume: 4, Issue:4

    Topics: Animals; Anthracenes; Benzodiazepines; CHO Cells; Chromans; Cricetinae; Cyclic Nucleotide-Gated Cati

2006
The inward rectification mechanism of the HERG cardiac potassium channel.
    Nature, 1996, Feb-29, Volume: 379, Issue:6568

    Topics: Animals; Arrhythmias, Cardiac; Cation Transport Proteins; Cell Line; DNA-Binding Proteins; Drosophil

1996